auranofin - CISMeF

Preferred Label : auranofin;

MeSH definition : An oral chrysotherapeutic agent for the treatment of rheumatoid arthritis. Its exact mechanism of action is unknown, but it is believed to act via immunological mechanisms and alteration of lysosomal enzyme activity. Its efficacy is slightly less than that of injected gold salts, but it is better tolerated, and side effects which occur are potentially less serious.;

CISMeF synonym : SmithKline beecham brand of auranofin; auranofin recordati brand; auranofin robapharm brand; auranofin rubio brand; auranofin yamanouchi brand; recordati brand of auranofin; robapharm brand of auranofin; rubio brand of auranofin; yamanouchi brand of auranofin;

MeSH hyponym : SK&F D 39162; crisinor; ridauran; ridaura; SK&F-39162; SK&F 39162; SK&F39162;

MeSH CAS label : gold, (1-thio-beta-D-glucopyranose 2,3,4,6-tetraacetato-S)(triethylphosphine)-;

MeSH Related Number : 34031-32-8 (Auranofin);

Registry Number MeSH : 34031-32-8;

Codes EINECS : 251-801-9;

Is substance : O;

UNII : 3H04W2810V;

InChIKey : AUJRCFUBUPVWSZ-XTZHGVARSA-M;

Details

Origin ID

D001310;

UMLS CUI

C0004320;

ATC code(s)
- auranofin [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
CISMeF manual mappings
- Auranofin adverse reaction (disorder) [SNOMED CT concept]
- auranofin [Substance BNPC]
Currated CISMeF NLP mapping
- Auranofin [ICD-11 Extension code]
- Auranofin [NCIt concept]
- Auranofin (substance) [SNOMED CT concept]
- Product containing auranofin (medicinal product) [SNOMED CT concept]
- auranofin [SNOMED Notion]
Pharmacological action(s)
- antirheumatic agents [MeSH Descriptor]
Record concept(s)
- SK&F D 39162 [MeSH concept]
- auranofin [MeSH concept]
- crisinor [MeSH concept]
- ridaura [MeSH concept]
- ridauran [MeSH concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Auranofin [ICD-11 Extension code]
- Auranofin [NCIt concept]
- Auranofin (substance) [SNOMED CT concept]
- Product containing auranofin (medicinal product) [SNOMED CT concept]
- auranofin [ATC Code]
- auranofin [Substance BNPC]
- auranofin [SNOMED Notion]
Validated automatic mappings to BTNT
- auranofin [ATC Code]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients